BALYASNY ASSET MANAGEMENT L.P. - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 110 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$451,434
+262.2%
67,580
+354.9%
0.00%
Q2 2023$124,633
-52.6%
14,855
-43.9%
0.00%
-100.0%
Q1 2023$262,937
+21.4%
26,479
-14.9%
0.00%0.0%
Q4 2022$216,595
+52.5%
31,120
+160.1%
0.00%0.0%
Q1 2021$142,00011,9640.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 124,096$583,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 875,931$4,117,0000.70%
Perceptive Advisors 2,885,458$13,417,0000.68%
683 Capital Management, LLC 525,093$2,442,0000.36%
Hikari Power Ltd 107,858$507,0000.07%
SABBY MANAGEMENT, LLC 97,704$454,0000.03%
Weiss Multi-Strategy Advisers LLC 62,000$288,0000.01%
ARDSLEY ADVISORY PARTNERS LP 29,104$136,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 475,000$2,209,0000.01%
Virtu KCG Holdings LLC 22,431$104,0000.00%
View complete list of ALDEYRA THERAPEUTICS INC shareholders